This inventor holds 1 USPTO granted patent. Top assignee: Beijing Baheal Chengchuang Pharmaceutical Research and Development Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yanlun Gu: Innovator in Anti-Cancer Compounds
Introduction
Yanlun Gu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds with anti-cancer properties. His innovative work has the potential to impact cancer treatment significantly.
Latest Patents
Yanlun Gu holds a patent for an indazole hydrazide compound and its applications. This compound, represented in formula (I), features R selected from substituted alkyl, substituted alkenyl, and substituted phenyl. The substituents in the substituted alkyl and substituted alkenyl include phenyl and/or substituted phenyl, while R′ is selected from H and alkyl. Compared to prior art, this indole hydrazide compound serves as an integrin avβ3 receptor antagonist. It exhibits notable anti-prostate cancer activity and demonstrates a significant inhibitory effect on enzalutamide-resistant cell lines. Furthermore, this compound has pronounced anti-tumor angiogenesis activity and can be utilized in the preparation of anti-tumor angiogenesis drugs to inhibit tumor angiogenesis. Yanlun Gu has 1 patent to his name.
Career Highlights
Yanlun Gu is currently employed at Beijing Baheal Chengchuang Pharmaceutical Research and Development Co., Ltd. His work at this company focuses on the research and development of innovative pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset in the fight against cancer.
Collaborations
Yanlun Gu collaborates with notable colleagues, including Yimin Cui and Xiaocong Pang. Their combined efforts contribute to advancing research in pharmaceutical development and enhancing the efficacy of cancer treatments.
Conclusion
Yanlun Gu is a dedicated inventor whose work in developing anti-cancer compounds holds promise for improving treatment options for patients. His innovative contributions to the field of pharmaceuticals are noteworthy and reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile